Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aceclofenac and Esomeprazole Interaction Study
NCT03127046Phase 1Unknown
- Sponsor
- Dongwha Pharmaceutical Co., Ltd.
- Start
- Mar 2017
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aceclofenac and esomeprazole in osteoarthritis (OA), rheumatoid arthritis (RA) and ankylosing spondylitis (AS) (6 arms), sponsored by Dongwha Pharmaceutical Co., Ltd. Primary endpoints: Maximum Plasma Concentration up to 24 hours and Area Under the Curve to the Last Measurable Concentration up to 24 hours. Status: unknown.
02
Drugs
aceclofenacesomeprazole
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT03127046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03127046.